Robert Buckheit Consulting | Pharmaceutical Product Development

Consulting Solutions

Dr. Robert W. Buckheit, Jr. is a well-established scientist and entrepreneur with more than 25 years of experience in pharmaceutical drug and biologic product development for the prevention and treatment of infectious disease and cancer. Dr. Buckheit's expertise as a scientist, business owner, and pharmaceutical product developer will bring immeasurable value to your company's products and development pathway. Read More

Professional Expertise and Experience

Dr. Buckheit received a B.S. in Biology from Lehigh University in 1982, a Ph.D. in Microbiology and Immunology from Duke University in 1986, and completed a postdoctoral fellowship at The University of North Carolina at Chapel Hill in 1989. Since 1989, Dr. Buckheit has been intimately involved in the preclinical development of anti-infective agents with a focus on prevention and therapeutic agents for use against HIV and the development of optimal combination drug regimens. During this period of time, Dr. Buckheit has scientifically and strategically developed and led infectious disease research programs for commercial, academic and government clients at Southern Research Institute, TherImmune Research Corporation/Gene Logic Inc., and ImQuest BioSciences, Inc. Read More

Publications

Novel preclinical models of topical PrEP and pharmacodynamics provide rationale for sutained intravaginal ring delivery of microbicide combinations.

Mesquita, P.M., Srinivasan, P., Johnson, T.J., Rastogi, R., Evans-Strickfaden, T., Kay, M.S., Buckheit, K.W., Buckheit, R.W., Jr., Smith, J.M., Kiser, P.F. and Herold, B.C., 2013